Last quarter (Q4 2022), Oneview Healthcare Chess Depository Interests repr 1's total revenue was $―, a decrease of ― from previous quarter. In Q4, Oneview Healthcare Chess Depository Interests repr 1's net income was $―. See Oneview Healthcare Chess Depository Interests repr 1’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	$ ―	$ 8.92M	$ 9.73M	$ 7.10M
Cost of Revenue	$ ―	$ 3.58M	$ 4.42M	$ 2.38M
Gross Profit	$ ―	$ 5.35M	$ 5.31M	$ 4.72M
Operating Expense	$ ―	$ 18.21M	$ 14.12M	$ 13.02M
Operating Income	$ ―	$ -12.86M	$ -8.81M	$ -8.29M
Net Non Operating Interest Income Expense	$ ―	$ -99.28K	$ 1.70K	$ -636.08K
Other Income Expense	$ ―	$ 1.36M	$ ―	$ -1.15M
Pretax Income	$ ―	$ -10.92M	$ -8.13M	$ -9.38M
Tax Provision	$ ―	$ -55.22K	$ 56.72K	$ 71.21K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -10.87M	$ -8.19M	$ -9.45M
Basic EPS	$ ―	$ -0.02	$ -0.02	$ -0.05
Diluted EPS	$ ―	$ -0.02	$ -0.02	$ -0.05
Basic Average Shares	$ ―	$ 522.32M	$ 431.35M	$ 186.25M
Diluted Average Shares	$ ―	$ 522.32M	$ 431.35M	$ 186.25M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -10.87M	$ -8.19M	$ -9.45M
Normalized Income	$ ―	$ -10.87M	$ -8.19M	$ -8.65M
Interest Expense	$ ―	$ 89.37K	$ 118.62K	$ 512.12K
EBIT	$ ―	$ -10.84M	$ -8.01M	$ -8.87M
EBITDA	$ ―	$ -10.16M	$ -7.33M	$ -8.18M

Currency in USD

Oneview Healthcare Chess Depository Interests repr 1 Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing